Andrew A. Lukowiak, Ph.D.

Chief Executive Officer

Dr. Lukowiak joins Millennium with almost 20 years of management experience in the molecular diagnostics space. Most recently, Dr. Lukowiak was Chief Operating Officer (COO) and interim-CEO of a commercial stage CLIA laboratory specializing in the combined use of genetics and algorithmic decision support to improve therapeutic outcomes. Prior to joining his previous company, Dr. Lukowiak held key positions at GenMark Diagnostics, Hologic, and Third Wave Technologies where he played a central role in the execution of the company’s clinical strategy; including the development of the first pharmacogenetic test to be cleared by the FDA for use with a specific drug. Dr. Lukowiak has managed a diverse set of departments and functions throughout his career including Operations, R&D, Quality/Regulatory Affairs, Scientific/Clinical Affairs, Customer Service, and Reimbursement. Dr. Lukowiak earned his doctorate in Genetics from the University of Georgia and his bachelor’s degree in Biology from Pennsylvania State University.